AstraZeneca
NEWS
Overnight, U.K. health authorities authorized the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use.
The United Kingdom is expected to give the green light to the vaccine developed by AstraZeneca and Oxford University this week.
An investigational asthma treatment, tezepelumab, under development by Amgen and AstraZeneca failed to reduce asthma patients’ dependence on corticosteroids.
The U.S. Food and Drug Administration has approved several drugs and medical devices in the last week. Here’s a look.
Many companies appear to be getting their clinical trial news updated ahead of the holidays. Here’s a look.
Vir Biotechnology and GlaxoSmithKline dosed the first patient in a new sub-trial of a Phase III study assessing the monoclonal antibody VIR-7831 as a potential treatment of hospitalized adults diagnosed with COVID-19.
Despite some setbacks, the company anticipates its vaccine could be available for use in the United Kingdom within the next several weeks.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.
The deal has been approved by both companies’ boards and is expected to close in the third quarter of 2021.
JOBS
IN THE PRESS